Literature DB >> 10504265

Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase.

J H Min1, M K Jain, C Wilder, L Paul, R Apitz-Castro, D C Aspleaf, M H Gelb.   

Abstract

Human plasma platelet activating factor acetylhydrolase (pPAF-AH) is a phospholipase A(2) that specifically hydrolyzes the sn-2 ester of platelet activating factor (PAF) and of phospholipids with oxidatively truncated sn-2 fatty acyl chains. pPAF-AH is bound to lipoproteins in vivo, and it binds essentially irreversibly to anionic and zwitterionic phospholipid vesicles in vitro and hydrolyzes PAF and PAF analogues. Substrate hydrolysis also occurs in the absence of vesicles, with a maximum rate reached at the critical micelle concentration. A novel pre-steady-state kinetic analysis with enzyme tightly bound to vesicles and with a substrate that undergoes slow intervesicle exchange establishes that pPAF-AH accesses its substrate from the aqueous phase and thus is not an interfacial enzyme. Such a mechanism readily explains why this enzyme displays dramatic specificity for phospholipids with short sn-2 chains or with medium-length, oxidatively truncated sn-2 chains since a common feature of these lipids is their relatively high water solubility. It also explains why the enzymatic rate drops as the length of the sn-1 chain is increased. pPAF-AH shows broad specificity toward phospholipids with different polar headgroups. Additional results are that PAF undergoes intervesicle exchange on the subminute time scale and it does not undergo transbilayer movement over tens of minutes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504265     DOI: 10.1021/bi991149u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Preferential hydrolysis of truncated oxidized glycerophospholipids by lysosomal phospholipase A2.

Authors:  Akira Abe; Miki Hiraoka; Hiroshi Ohguro; John J Tesmer; James A Shayman
Journal:  J Lipid Res       Date:  2016-12-19       Impact factor: 5.922

Review 3.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

4.  Specificity of lipoprotein-associated phospholipase A(2) toward oxidized phosphatidylserines: liquid chromatography-electrospray ionization mass spectrometry characterization of products and computer modeling of interactions.

Authors:  Vladimir A Tyurin; Naveena Yanamala; Yulia Y Tyurina; Judith Klein-Seetharaman; Colin H Macphee; Valerian E Kagan
Journal:  Biochemistry       Date:  2012-11-19       Impact factor: 3.162

5.  Lipoprotein-associated phospholipase A(2) interacts with phospholipid vesicles via a surface-disposed hydrophobic α-helix.

Authors:  Jian Cao; Yuan-Hao Hsu; Sheng Li; Virgil L Woods; Edward A Dennis
Journal:  Biochemistry       Date:  2011-05-17       Impact factor: 3.162

Review 6.  The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Authors:  Salim S Virani; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

7.  Crystallization and preliminary X-ray crystallographic analysis of human plasma platelet activating factor acetylhydrolase.

Authors:  Uttamkumar Samanta; Cheryl Wilder; Brian J Bahnson
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

8.  Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.

Authors:  Uttamkumar Samanta; Brian J Bahnson
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

Review 9.  Using hydrogen/deuterium exchange mass spectrometry to define the specific interactions of the phospholipase A2 superfamily with lipid substrates, inhibitors, and membranes.

Authors:  Jian Cao; John E Burke; Edward A Dennis
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.